BLRX logo

BioLineRx (BLRX) Net Income

Annual Net Income

-$60.61 M
-$35.66 M-142.93%

December 31, 2023


Summary


Performance

BLRX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLRXprofitabilitymetrics:

Quarterly Net Income

-$5.82 M
-$6.31 M-1302.89%

September 1, 2024


Summary


Performance

BLRX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLRXprofitabilitymetrics:

TTM Net Income

-$19.92 M
+$10.20 M+33.87%

September 1, 2024


Summary


Performance

BLRX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLRXprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

BLRX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-142.9%+63.7%+62.0%
3 y3 years-101.9%-1.9%+42.7%
5 y5 years-164.0%-1.9%+42.7%

BLRX Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-142.9%at low-1302.9%+68.6%at high+67.1%
5 y5-year-142.9%at low-1302.9%+68.6%at high+67.1%
alltimeall time-2990.5%at low-129.1%+68.6%-332.6%+67.1%

BioLineRx Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.82 M(-1302.9%)
-$19.92 M(-33.9%)
Jun 2024
-
$484.00 K(-169.5%)
-$30.12 M(-38.7%)
Mar 2024
-
-$696.00 K(-95.0%)
-$49.15 M(-18.9%)
Dec 2023
-$60.61 M(+142.9%)
-$13.88 M(-13.3%)
-$60.61 M(+15.5%)
Sep 2023
-
-$16.02 M(-13.6%)
-$52.46 M(+21.2%)
Jun 2023
-
-$18.55 M(+52.5%)
-$43.28 M(+34.5%)
Mar 2023
-
-$12.16 M(+112.2%)
-$32.18 M(+29.0%)
Dec 2022
-$24.95 M(-7.8%)
-$5.73 M(-16.3%)
-$24.95 M(+6.1%)
Sep 2022
-
-$6.85 M(-8.0%)
-$23.52 M(+5.1%)
Jun 2022
-
-$7.44 M(+51.0%)
-$22.39 M(+2.8%)
Mar 2022
-
-$4.93 M(+14.5%)
-$21.79 M(-19.4%)
Dec 2021
-$27.05 M(-9.9%)
-$4.30 M(-24.7%)
-$27.05 M(-22.1%)
Sep 2021
-
-$5.72 M(-16.5%)
-$34.74 M(+3.3%)
Jun 2021
-
-$6.84 M(-32.9%)
-$33.64 M(+0.2%)
Mar 2021
-
-$10.19 M(-15.0%)
-$33.57 M(+11.8%)
Dec 2020
-$30.02 M(+18.0%)
-$11.99 M(+159.6%)
-$30.02 M(+7.6%)
Sep 2020
-
-$4.62 M(-31.8%)
-$27.90 M(+2.5%)
Jun 2020
-
-$6.77 M(+1.9%)
-$27.22 M(+5.0%)
Mar 2020
-
-$6.64 M(-32.7%)
-$25.94 M(+1.9%)
Dec 2019
-$25.45 M(+10.8%)
-$9.87 M(+150.6%)
-$25.45 M(+19.9%)
Sep 2019
-
-$3.94 M(-28.2%)
-$21.23 M(-10.1%)
Jun 2019
-
-$5.49 M(-10.9%)
-$23.62 M(+3.0%)
Mar 2019
-
-$6.16 M(+8.9%)
-$22.92 M(-0.2%)
Dec 2018
-$22.96 M(-5.7%)
-$5.65 M(-10.6%)
-$22.96 M(-6.9%)
Sep 2018
-
-$6.32 M(+32.1%)
-$24.67 M(-3.6%)
Jun 2018
-
-$4.79 M(-22.7%)
-$25.59 M(-0.4%)
Mar 2018
-
-$6.20 M(-15.8%)
-$25.70 M(+5.5%)
Dec 2017
-$24.35 M
-$7.36 M(+1.6%)
-$24.35 M(+14.4%)
Sep 2017
-
-$7.24 M(+47.9%)
-$21.28 M(+15.8%)
DateAnnualQuarterlyTTM
Jun 2017
-
-$4.90 M(+0.9%)
-$18.37 M(+6.8%)
Mar 2017
-
-$4.86 M(+13.3%)
-$17.21 M(+8.6%)
Dec 2016
-$15.84 M(+10.0%)
-$4.29 M(-1.1%)
-$15.84 M(+4.2%)
Sep 2016
-
-$4.33 M(+16.0%)
-$15.21 M(+21.7%)
Jun 2016
-
-$3.73 M(+7.1%)
-$12.50 M(-7.9%)
Mar 2016
-
-$3.49 M(-4.5%)
-$13.58 M(-5.7%)
Dec 2015
-$14.40 M(+30.0%)
-$3.65 M(+124.6%)
-$14.40 M(-3.6%)
Sep 2015
-
-$1.63 M(-66.2%)
-$14.94 M(+6.6%)
Jun 2015
-
-$4.81 M(+11.6%)
-$14.01 M(+5.6%)
Mar 2015
-
-$4.31 M(+2.8%)
-$13.27 M(+19.8%)
Dec 2014
-$11.08 M(-34.9%)
-$4.19 M(+499.0%)
-$11.07 M(+0.7%)
Sep 2014
-
-$700.00 K(-82.8%)
-$10.99 M(-27.9%)
Jun 2014
-
-$4.07 M(+92.3%)
-$15.24 M(-1.3%)
Mar 2014
-
-$2.12 M(-48.6%)
-$15.44 M(-8.3%)
Dec 2013
-$17.02 M(-16.6%)
-$4.11 M(-17.0%)
-$16.84 M(-15.7%)
Sep 2013
-
-$4.95 M(+16.0%)
-$19.99 M(-3.8%)
Jun 2013
-
-$4.27 M(+21.4%)
-$20.77 M(+7.1%)
Mar 2013
-
-$3.51 M(-51.6%)
-$19.40 M(-6.3%)
Dec 2012
-$20.42 M(+54.8%)
-$7.25 M(+26.5%)
-$20.71 M(+21.6%)
Sep 2012
-
-$5.74 M(+98.4%)
-$17.03 M(+27.0%)
Jun 2012
-
-$2.89 M(-40.1%)
-$13.41 M(-12.4%)
Mar 2012
-
-$4.83 M(+35.0%)
-$15.31 M(+10.9%)
Dec 2011
-$13.19 M(-728.8%)
-$3.58 M(+68.7%)
-$13.81 M(-14.8%)
Sep 2011
-
-$2.12 M(-55.8%)
-$16.21 M(-374.7%)
Jun 2011
-
-$4.79 M(+44.1%)
$5.90 M(+71.6%)
Mar 2011
-
-$3.32 M(-44.3%)
$3.44 M(+32.6%)
Dec 2010
$2.10 M
-$5.97 M(-129.9%)
$2.59 M(-69.7%)
Sep 2010
-
$19.99 M(-375.6%)
$8.56 M(-175.0%)
Jun 2010
-
-$7.25 M(+73.9%)
-$11.42 M(+173.9%)
Mar 2010
-
-$4.17 M
-$4.17 M

FAQ

  • What is BioLineRx annual net profit?
  • What is the all time high annual net income for BioLineRx?
  • What is BioLineRx annual net income year-on-year change?
  • What is BioLineRx quarterly net profit?
  • What is the all time high quarterly net income for BioLineRx?
  • What is BioLineRx quarterly net income year-on-year change?
  • What is BioLineRx TTM net profit?
  • What is the all time high TTM net income for BioLineRx?
  • What is BioLineRx TTM net income year-on-year change?

What is BioLineRx annual net profit?

The current annual net income of BLRX is -$60.61 M

What is the all time high annual net income for BioLineRx?

BioLineRx all-time high annual net profit is $2.10 M

What is BioLineRx annual net income year-on-year change?

Over the past year, BLRX annual net profit has changed by -$35.66 M (-142.93%)

What is BioLineRx quarterly net profit?

The current quarterly net income of BLRX is -$5.82 M

What is the all time high quarterly net income for BioLineRx?

BioLineRx all-time high quarterly net profit is $19.99 M

What is BioLineRx quarterly net income year-on-year change?

Over the past year, BLRX quarterly net profit has changed by +$10.20 M (+63.66%)

What is BioLineRx TTM net profit?

The current TTM net income of BLRX is -$19.92 M

What is the all time high TTM net income for BioLineRx?

BioLineRx all-time high TTM net profit is $8.56 M

What is BioLineRx TTM net income year-on-year change?

Over the past year, BLRX TTM net profit has changed by +$32.54 M (+62.03%)